Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
What is City Talk? City Talk allows marketers to connect directly with our audience by publishing content on citypm.eu
Friday 21 October 2022 12:20 pm  |  Updated:  Monday 13 February 2023 5:09 pm

Curing blindness in some of the most isolated regions of Nepal

By: The Tej Kohli and Ruit Foundation

Add as a preferred source on Google

In March 2022, the Tej Kohli & Ruit Foundation staged one of the biggest mountainous area cataract microsurgical camps ever organized in Nepal. It was here that 333 patients returned home with full vision after their blindness was cured. Whilst this was ongoing, another team working with the foundation were busy screening patients in Nepal’s plains for another scheduled microsurgical camp.

The team organised 7 screening camps from the 15th to the 22nd of March with a special focus on reaching out to extremely marginalised communities of the region, who were most likely to be unable to afford or access cataract surgery due to their socioeconomic status. 

2,206 people from three districts, (Bara, Rautahat and Parsa) were screened for any form of visual impairment, of which more than 300 patients were identified to have been living with cataract blindness. 

They were then invited for their free surgeries at a Tej Kohli & Ruit Foundation microsurgical camp in Nijgad on the 24th, 25th and 26th of March, 2022. On the 23rd of March 2022, a team from the Tilganga Institute of Ophthalmology along with a few other team members from Hetauda Community Eye Centre made their way to Nijgad. 

Despite the areas being much more well-connected than Nepal’s hilly regions, it is one of the regions with one of the highest cataract prevalence in the country. According to a report by Nepal’s Department of Health Services, the “Proportion of untreated cataracts remains highest in Province 2 (88.5%)”. The report further outlines barriers to the uptake of cataract surgery as “affordability, accessibility, lack of felt need, and fear of surgery”, in that order.

The Tej Kohli & Ruit Foundation, which has cured over 13,000 patients of cataract blindness in its first year, continues to make efforts towards tackling each barrier as mentioned by the report. The Tej Kohli & Ruit Foundation eliminates the problem of affordability by providing free surgery, improves accessibility by taking its outreach camps to some of the most underserved regions of Nepal, and provides counselling to patients living with cataract blindness on the need of surgery, while providing quality cataract surgeries which is second to none.

Once at Nijgad, the team set up an operating theatre, a biometrics lab, an anaesthetic ward, a sterilisation room, and a post-operative ward which are all a part of a mobile cataract surgical delivery system perfected by Dr Sanduk Ruit. Dr Ruit, who has taken his mobile surgical delivery system to some of the most underserved regions of not only Nepal but across Asia and Africa, wishes to use his life’s work by curing as many as half a million people of needless blindness by 2030. Mr Kohli, who believes that in order to end poverty we must invest in curing the developing world’s needlessly blind, is enthusiastic about his partnership with Dr Ruit and is keen to make the movement a worldwide movement to eliminate needless blindness with an overarching mission to reduce extreme poverty in the developing world.

On the 24th, surgeries quickly began. Patients began arriving early at the camp holding their referral papers. Once at the camp, the medical team conducted their biometrics and began ushering one patient after the other to the operating theatre. The operating team, led by Dr Govinda Paudyal, a highly regarded cataract and vitreo-retina surgeon, skillfully removed one cataract after another. In three days, Dr Paudyal conducted more than 200 cataract surgeries.

Patients arriving at the camp were of different races and from various communities – however, all living a life of needless blindness due to untreated cataracts. Patients included Kanchi Maya Ghising, who was born deaf, but only became blind recently. Already living with a hearing impairment, her visual impairment added an extra burden on her family members’ lives. 

After a successful surgery by Dr Paudyal, she along with her sight also rediscovered her smile. Along with Kanchi, patients like Junglee Majhi, a member of Rautahat’s Dalit community, whose family has been unable to overcome the cycle of poverty due to their social status received a second chance to sight at the Nijgad eye camp. Similarly, 80-year-old Buhari Chaudhary, who had lost all hopes of seeing again, was stunned to receive a second chance at sight.

She longed to return home and look at her great-grandchildren again.

Read more

Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Life&Style

Categories

  • Charity
  • Culture

Trending Articles

  • Burnham told to launch £100bn tax reform package

  • Billionaire Easyjet founder in line for £800m payday from takeover

  • Construction sector cuts jobs again as house building slumps

  • Harry Styles at Wembley Stadium review: running through the grief

  • Tickets for England World Cup quarter vs Norway on sale for $8m

More from City PM

  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire
  • LivaNova Demonstrates 84.5% Cumulative Response Rate with PolySync Programming in OSPREY Study for Obstructive Sleep Apnea

    Business Wire
  • Alkermes to Present New Data on Alixorexton and LUMRYZ® (sodium oxybate) at SLEEP 2026, Highlighting Breadth of Sleep Medicine Research

    Business Wire
  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • Harley Street Health District Releases First Annual Impact Report

    Business Wire
  • GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares

    Tech
    GSK said total sales fell by two per cent in the third quarter
  • IMU Biosciences announces oversubscribed financing round, bringing its Series A to over $53M as it accelerates its work to decode the immune system with unprecedented resolution and scale, to transform how we understand, diagnose and treat disease

    Business Wire
  • cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy